Saturday, October 3, 2026

SK Biopharmaceuticals Selects Two CNS Startups Through Open Innovation… Advances Expected in Parkinson’s and Alzheimer’s Treatment

SK Biopharmaceuticals partners with Seoul Bio Hub to support two CNS startups, Novorex and Threebrooks, in innovative drug development.

LG Chem’s FMC-220: A Breakthrough Cancer Drug Targeting the p53 Y220C Mutation

LG Chem secures exclusive rights to FMC-220, a cancer drug targeting the p53 Y220C mutation, aiming for Phase 1 trials.

AI in Healthcare: How SEERS is Revolutionizing Arrhythmia Diagnosis in the UAE

SEERS is advancing the commercialization of AI-based arrhythmia diagnosis in the UAE, expanding its reach in the Middle East market.

Yoon Mi Jeong

Author's Latest

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.